Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
No.
Read the rest of the update and you will see that they have enough cash to cover at least two of the payments, and that there are other funding options.
“. It is intended that the Company will pay DSM for this inventory over the course of a three month sale back period, commencing on 1 January 2023, with payments due equally (amounting to one third of DSM's 31 December 2022 inventory) on 31 January 2023, 28 February 2023 and 31 March 2023. “ So are we expecting an Rns at the end of the month as the bod have to find approx £330 k in one way or another !
Didn't need to.
The issue with scientific products is that their creators are so enamoured with the ability to control a specific body function that they are prepared to overlook known adverse effects IMHO. Having a product here that has no such adverse effects should benefit us greatly, except that the industry has far more resources to keep control of the narrative. However, there must be enough educated consumers who can differentiate. If only we can reach them.
I expect many on here have googled "statin side effects" this morning.
Massive opportunity here for us if we can get the message out there that there is a natural alternative to combat strokes and CVD that has no side effects - just need to get the cost down.
From a friend's personal experience there may be a synergistic effect of FF and statins on bp.
W$
Very Interesting read
"In September, BY-HEALTH's latest research achievement "Water-soluble tomato concentrate modulates shear-induced platelet aggregation and blood flow in vitro and in vivo" (Water-soluble tomato concentrate WSTC regulates platelet aggregation and blood flow) was published in the authoritative scientific journal "Frontiers Published in "in Nutrition" (Nutrition Frontiers), revealing the new mechanism of "water-soluble tomato concentrate Fruitflow ® ", i.e., the activity of chrysanthemum to improve blood flow health, marking BY-HEALTH's innovation and development of new functions to a new level".
That one was an official press release from By-Health.
http://www.by-health.com/news-4588
A new Chinese article referencing the SIPA study.
https://www.prnasia.com/story/376755-1.shtml
I believe everything that women says, I didnt get the information from the BBC and certainly not from her.
and maybe
https://up4products.com
or
https://estroven.com
a couple more of their brands.
I am hoping that DSM lead the way and include FF in their Culterelle Brand. Given the gut health study results, it seems the obvious place to start.
https://www.culturelle.com
tootight , no it was X 5 from the height of CV19 , you dont think the BBC are telling you the truth do you !
https://www.youtube.com/watch?v=fBQpQAw2MuE
In the following link the top word is Provexis's trademark for Fruitflow. As David says "QINGLUOSU"
The bottom is By-Healths Trademark for a product that contains Fruitflow and I believe something else (I forget what),XINLUOSU, and it was originally the name of a sports product that was going to launch back around 2017 before all the regulatory work started.
https://translate.google.co.uk/?sl=auto&tl=en&text=%E8%BD%BB%E7%BB%9C%E7%B4%A0%0A%E6%96%B0%E7%BB%9C%E7%B4%A0%0A&op=translate
So long as it's Fruitflow, I don't mind what they call it :)
sorry, fat fingers, posted too early
they used XINLUOSU Tablet in this trial, which I think it will be the name of product that launched by BH in the future
BH is promoting fruitflow as QINGLUOSU in Chinese.
B
Very similar with some minor differences, but mainly different people funding it. Perhaps the original one was being delayed and then BH jumped in to fund it themselves.
Here is the one I was thinking of.
Date of Last Refreshed on:2022-11-16
https://www.chictr.org.cn/showprojen.aspx?proj=129186
Hi Dr -H, yes and there is another similar to this that has been updated recently but not on my p.c. atm to provide the link.
I wondered, because of the date in the link I posted, whether it may be the trial starting up again after Covid.
Just a guess though.
Primary sponsor:
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Source(s) of funding:
Self-financing
So it is not a By-Health study.
This is very good. It shows that the aim is to use FF for primary prevention.
Gix,
There is more data in this link:
https://www.chictr.org.cn/showproj.aspx?proj=130349
The purpose of this study is to evaluate the effect and safety of Xinluosu Tablets on platelet function in healthy population, so as to prevent abnormal platelet activation and aggregationand reduce the risk of cardiovascular disease.
Size: 50 people
Tablet size: 300mg
Institution: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Age 35 - 65 years
Sex: Both
Outcomes:
platelet aggregation function - Primary indicator
platelet activating function - Primary indicator
platelet release function - Primary indicator
platelet adhesion function - Primary indicator
stature - Secondary indicator
weight - Secondary indicator
waist circumference - Secondary indicator
hip circumference - Secondary indicator
blood pressure - Secondary indicator
heart rate - Secondary indicator
Score of TCM constitution - Secondary indicator
blood routine test - Secondary indicator
hepatic function test - Secondary indicator
renal function test - Secondary indicator
blood lipid test - Secondary indicator
hemagglutination test - Secondary indicator
Whatever the cause, excess myocarditis is a factor worthy of much discussion. The US bloggers are all over it, but it seems big pharma were handed a free pass.
Then again, Bern says we have to accept the science, gawd I wish I had a quid for every time I've read that.
"The important thing is not to stop questioning. Curiosity has its own reason for existing" Albert Einstein.
" If its settled it isn't science, and if it's science, it isn't settled" Michael Crichton
excess deaths in the run-up to Christmas were a fifth more than the five-year average. Slightly less than 5x more
I should add that I am unvaxd it is the vaxd that gets cv19 more than once from my observations. Excess deaths now 5 times higher than at the height of CV19 but the MSM are ignoring it .
I haven't had cv19 , I take FF , Chlorine Dioxide in a nebuliser if I feel I might be getting a cold and I take Ivermectin once a month 12 mgs and ZInc and Vit D vit K2 . People getting it now are reporting it is just a bad cold even so I don't like colds.